N4 Pharma PLC (N4P)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.50p
Buy
0.55p
0.024p (+4.57%)
Prices updated at 19 Dec 2025, 09:22 GMT
| Prices minimum 15 mins delay
Prices in GBX
N4 Pharma PLC is a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance. Its vaccines include Nuvac and Nuvec.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 1,953 | 7,282 | |
| 1,953 | 7,282 | |
| -1m | -1m | |
| -68,377.83 | -15,928.19 | |
| -1m | -1m | |
| -1m | -1m | |
| Sales, General and administrative | 486,202 | 551,559 |
| Interest expenses | - | - |
| Provision for income taxes | -147,816 | -101,112 |
| Operating expenses | 1m | 1m |
| Income before taxes | -1m | -1m |
| Net income available to common shareholders | -1m | -1m |
| -0.0052 | -0.0031 | |
| Net interest income | - | - |
| Advertising and promotion | - | - |
| Net investment income, net | -89,175 | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.0052 | -0.0031 |
| Free cash flow per share | -0.0059 | -0.0036 |
| Book value/share | 0.0054 | 0.0032 |
| Debt equity ratio | - | - |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 1m | 775,769 |
| Current liabilities | 81,726 | 124,367 |
| Total capital | 1m | 647,647 |
| Total debt | - | - |
| Total equity | 1m | 647,647 |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 1m | 775,769 |
| Total liabilities | - | - |
| Cash and cash equivalents | 1m | 625,972 |
| Common stock | 269m | 395m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 2m | 1m |
| Cash dividends paid | - | - |
| -1m | -971,500 | |
| Investments (gains) losses | 781 | - |
| 1m | 625,972 | |
| Net income | - | - |
| -1m | -971,500 | |
| - | - |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
